BioPharma Dive

MARCH 29, 2025

In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed “misinformation and lies.

Vaccines 123

Vaccines 123

Pharmacy Times

MARCH 29, 2025

Rivaroxaban offers more predictable dosing, eliminates frequent blood tests, and is less likely to interact with foods.

33

33

Pharmacist Money Blog

MARCH 29, 2025

Image via PexelsImage via Pexels Financial Planning for Young Families: Building a Secure Future Starting a family is one of lifes most rewarding milestonesbut it also comes with new responsibilities, especially when it comes to money. From saving for your childrens education to preparing for unexpected expenses, smart financial planning is essential for ensuring a secure and stress-free future.

52

52

Pharmacy Times

MARCH 29, 2025

Christian Ruff, MD, highlights abelacimabs potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.

29

29

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

MARCH 29, 2025

Welcome to Lab Dish , a new First Opinion column on regenerative medicine from Paul Knoepfler. There are certain leaders who quietly make complex organizations operate well including in the toughest of times—leaders like Peter Marks, director of the Center for Biologics Evaluation and Research (CBER), who resigned Friday. Marks’ effectiveness at the Food and Drug Administration saved countless lives and greatly advanced the cell and gene therapy field.

Vaccines 360

Vaccines 360

STAT

MARCH 29, 2025

When Robert F. Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be the nation’s health secretary, the head of biotech’s largest trade group issued a statement saying that he had “every confidence” that the industry would “continue to thrive and deliver” on its goals, and looked forward to working closely with the new administration.

Vaccines 362

Vaccines 362

Pharmacy Times

MARCH 29, 2025

The results should lead to a guideline update recommending extended treatment with a reduced-dose anticoagulant in this patient population.

29

29

Pharmacy Times

MARCH 29, 2025

PD-L1 immune checkpoint inhibitors are now standard for early-stage non-metastatic non-small cell lung cancer (NSCLC), with neoadjuvant, adjuvant, and perioperative strategies improving survival and outcomes.

Immunization 26

Immunization Immunity 26

Pharmacy Times

MARCH 29, 2025

The DapaTAVI study is the first trial of a sodium-glucose cotransporter-2 (SGLT2) inhibitor for valvular disease.

20

20

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharmacy Times

MARCH 29, 2025

The STRIDE trial was first of its kind to evaluate the use of a GLP-1 agonist in PAD management.

Diabetes 52

Diabetes 52